Mr. Speaker, the lack of a reliable supply of medical isotopes is a serious situation that the government takes very seriously and is addressing in a global manner. In the long term, it is important for Canadians to have a secure and reliable supply of medical isotopes.
That is why I am very pleased to announce today that Peter Goodhand, president and CEO of the Canadian Cancer Society; Dr. Tom Mason, director of the Oak Ridge National Laboratory in the United States; Richard Drouin, former chair of the North American Electric Reliability Corporation; and Dr. Eric Turcotte, head of the Molecular Imaging Centre of Sherbrooke have agreed to serve on our expert review panel.